selected publications
- CD8+ T Cell-Dependent Antitumor Activity In Vivo of a Mass Spectrometry-Identified Neoepitope despite Undetectable CD8+ Immunogenicity In Vitro. Journal of immunology (Baltimore, Md. : 1950). 2023 Academic Article GET IT
- APR-246 increases tumor antigenicity independent of p53. Life science alliance. 2023 Academic Article GET IT
- Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine. Science translational medicine. 2022 Academic Article GET IT
-
An unbiased approach to defining bona fide cancer neoepitopes that elicit immune-mediated cancer rejection.
The Journal of clinical investigation.
2021
Academic Article
GET IT
Times cited: 19 -
Neoepitopes as cancer immunotherapy targets: key challenges and opportunities.
Immunotherapy.
2017
Review
GET IT
Times cited: 52 -
Zinc Induces Dendritic Cell Tolerogenic Phenotype and Skews Regulatory T Cell-Th17 Balance.
Journal of immunology (Baltimore, Md. : 1950).
2016
Academic Article
GET IT
Times cited: 55